TEALE FENNING Forum Index TEALE FENNING
Medical Education
 
 FAQFAQ   SearchSearch   MemberlistMemberlist   UsergroupsUsergroups   RegisterRegister 
 ProfileProfile   Log in to check your private messagesLog in to check your private messages   Log inLog in 

Layterms: How do you explain sensitivity and specificity?

 
Post new topic   Reply to topic    TEALE FENNING Forum Index -> MRCOG Part 2: Objective Structured Clinical Examination - the OSCE
View previous topic :: View next topic  
Author Message
Nick Raine-Fenning
Course Director


Joined: 27 May 2006
Posts: 1852
Location: Nottingham

PostPosted: Sat Oct 21, 2006 3:09 pm    Post subject: Layterms: How do you explain sensitivity and specificity? Reply with quote

During this weekends Theoretical OSCE Course we discussed how to explain things to patients in layterms.

Several of you made some excellent suggestions so I thought I would start a series of "Layterm Posts" where I want you to explain in simple, non-medical words that are understandable to the general public.

Let's start with sensitivity and specificity! Cool

You are asked to discuss screening for Down syndrome. During the 'role play' you come to the point where you need to explain the sensitivity and specificity of nuchal translucency.

How do you explain this to the patient?
_________________
"Teale Fenning Medical Education" delivering evidence-based, exam-orientated learning since 1997
Back to top
View user's profile Send private message Send e-mail Visit poster's website
chandra



Joined: 21 Oct 2006
Posts: 6

PostPosted: Sun Oct 22, 2006 5:45 pm    Post subject: Reply with quote

Nuchal thickness is measurement of neck skin thickness in fetus between 11wks to 14 wks by ultrasound scan.

This is a screening test - that which identifies high risk fetuses for chromosomal abnormalities.

The test has a detection rate of 70% and false positive rate of 5%

sensitivity is the probability of a positive test among patients with disease specificity is the probability of a negative test among patients without disease
_________________
chandra
Back to top
View user's profile Send private message
Nick Raine-Fenning
Course Director


Joined: 27 May 2006
Posts: 1852
Location: Nottingham

PostPosted: Mon Oct 23, 2006 8:53 am    Post subject: Reply with quote

No - how do you explain this to a patient? - that is what we mean by layterms.

Last edited by Nick Raine-Fenning on Mon Oct 23, 2006 9:12 am; edited 1 time in total
Back to top
View user's profile Send private message Send e-mail Visit poster's website
Nick Raine-Fenning
Course Director


Joined: 27 May 2006
Posts: 1852
Location: Nottingham

PostPosted: Mon Oct 23, 2006 9:11 am    Post subject: Reply with quote

chandra wrote:
Nuchal thickness is measurement of neck skin thickness in fetus between 11wks to 14 wks by ultrasound scan.


Measurement of the thickness of the skin at the back of the neck made between 11 weeks and 3 days and 13 completed weeks (i.e. 13 weeks 6 days)


chandra wrote:
This is a screening test - that which identifies high risk fetuses for chromosomal abnormalities. The test has a detection rate of 70% and false positive rate of 5%. Sensitivity is the probability of a positive test among patients with disease specificity is the probability of a negative test among patients without disease


That's not entirely true as it also identifies many fetuses who are not high risk - be careful how you say this to patients.

A screening test is a test that alters an individuals risk to give a more accurate prediction of their risk. It is usually applied to the general population. A screening test does not, therefore, tell you if the individual (in this case a fetus) is affected. This requires further tests known as a 'diagnostic test'. The decision to go ahead with a diagnostic test will depend on the new calculated level of risk and the individuals wishes.

No screening test is 100% accurate. Some individuals who are affected (in this case, fetuses with Down syndrome) will be missed. The ability of a test to detect all affected individuals is referred to as its sensitivity. For NT measurements this may be as high as 80% meaning it should accurately indicate a higher risk in 80 of 100 women who have a fetus with Down syndrome. Unfortunately this means 20 women who have an affected fetus will be falsely reassured by a low risk result.

Furthermore screening tests can sometimes suggest an individual is at an increased risk of being affected when they are in fact entirely normal. This is know as the specificity of the test. In the cas of NT measurements, for every 100 women with a unaffected fetus, 5 will be incorrectly told that they are at increased risk.

In summary. it is important to always remember that the result of a screening test is just a estimate of risk. The result may be falsely reassuring or falsely worrying. Ultimately the interpretation of the test result depends on how the person feels about the condition being looked for and their own interpretation of risk. For some individuals a risk of 10% may seem acceptable whilst for others a risk of 1% may seem unacceptably high.
_________________
"Teale Fenning Medical Education" delivering evidence-based, exam-orientated learning since 1997
Back to top
View user's profile Send private message Send e-mail Visit poster's website
Display posts from previous:   
Post new topic   Reply to topic    TEALE FENNING Forum Index -> MRCOG Part 2: Objective Structured Clinical Examination - the OSCE All times are GMT
Page 1 of 1

 
Jump to:  
You cannot post new topics in this forum
You cannot reply to topics in this forum
You cannot edit your posts in this forum
You cannot delete your posts in this forum
You cannot vote in polls in this forum


Powered by phpBB © 2001, 2005 phpBB Group